The value of screening for prostate cancer using serum prostate-specific antigen (PSA) remains controversial even after the publication of the two major randomised controlled trials of screening (Andriole et al, 2009; Schroder et al, 2009). Here, KLK3 is linked to Familial prostate cancer.